Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations and a primary focus in hematology and oncology, today announced positive results from the BELIEF trial, a pivotal, single-arm study of belinostat in patients with relapsed or refractory peripheral T-cell lymphoma (R/R PTCL) after failure of =1 prior systemic therapies.
Help employers find you! Check out all the jobs and post your resume.
